Protein is the major source of building material for muscles, blood, skin, hair, nails, and the internal organs. It is necessary for the formation of many hormones, enzymes, and antibodies and may act as a source of energy.
Zofran (ondansetron) is an antiemetic and selective 5-HT3 receptor antagonist prescribed for the treatment of nausea and vomiting due to cancer chemotherapy and also used to prevent and treat nausea and vomiting after surgery. Zofran is available in generic form. Common side effects of Zofran include: diarrhea, headache, fever, lightheadedness, dizziness, weakness, tiredness, drowsiness, constipation, rash, blurred vision, and; muscle spasm. Zofran adult dose is 32-mg given as a single dose or divided in three 0.15-mg/kg divided doses infused over 15 minutes.
Zofran has proven to be an effective medication to treat nausea and vomiting, but the medication never gained federal approval for use in pregnant women. Despite the lack of approval, women battling morning sickness took Zofran, Zuplenz (similar drug) or ondansetron (generic version) which some families claim led to birth defects. Zofran is approved to prevent nausea and vomiting caused by chemotherapy, radiation and surgery.